As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Tonix Pharmaceuticals Holding Corp. The largest reported stake is Point72 Asset Management, L.P.'s, at 6.9%. 12 filings are on record since July 17, 2025 (Schedule 13G/A, May 15, 2026).
Sell to companies like Tonix Pharmaceuticals Holding Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Sirenia Capital Management LP · Sole voting: 0 · Shared voting: 814,801 · Sole dispositive: 0 · Shared dispositive: 814,801 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: AQR Capital Management, LLC · Sole voting: 0 · Shared voting: 866,867 · Sole dispositive: 0 · Shared dispositive: 882,595 · SCHEDULE 13G, 2026-08-13
- · Reporting person: Millennium Management LLC · Sole voting: 0 · Shared voting: 890,366 · Sole dispositive: 0 · Shared dispositive: 890,366 · SCHEDULE 13G, 2026-06-15
- · Holder: Sirenia Capital Management LP · Percent: 8.8% · SCHEDULE 13G
- · Holder: Point72 Asset Management, L.P. · Percent: 6.9% · SCHEDULE 13G/A
Tonix Pharmaceuticals Holding Corp. has 12 Schedule 13D or 13G filings on record since 2025-07-17. 4 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 6.9% | 1,100,964 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| BlackRock, Inc. | 6.7% | 854,579 | SCHEDULE 13G/A, 2026-01-21 | 2025-12-31 |
| Millennium Management LLC | 5.6% | 890,366 | SCHEDULE 13G, 2026-06-15 | 2026-06-09 |
| AQR Capital Management, LLC | 5.54% | 882,595 | SCHEDULE 13G, 2026-08-13 | 2026-06-30 |
| Sirenia Capital Management LP | 4.9% | 814,801 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Tonix Pharmaceuticals Holding Corp. and the warning signs.
Free to see. No signup.
Keep reading
More on Tonix Pharmaceuticals Holding Corp. and the records around it.
Tonix Pharmaceuticals Holding Corp. elsewhere on the record
Companies that share a holder
- Sirenia Capital Management LP also filed stake reports on 19 other companies: Alto Neuroscience, Inc. (Aug 2026), ANAPTYSBIO, INC (Aug 2026), CYBIN INC. (Aug 2026)
- Point72 Asset Management, L.P. also filed stake reports on 90 other companies: Immunocore Holdings plc (Nov 2026), Target Hospitality Corp. (Nov 2026), E.W. SCRIPPS Co (Oct 2026)
- Millennium Management LLC also filed stake reports on 121 other companies: StepStone Group Inc. (Nov 2026), Catalyst Acquisition Corp. (Nov 2026), RxSight, Inc. (Nov 2026)
Watch Tonix Pharmaceuticals Holding Corp.
Get an email when Tonix Pharmaceuticals Holding Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Tonix Pharmaceuticals Holding Corp.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Tonix Pharmaceuticals Holding Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Tonix Pharmaceuticals Holding Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Millennium Management LLC | 0 | 890,366 | 0 | 890,366 | SCHEDULE 13G, 2026-06-15 |
| Millennium Group Management LLC | 0 | 890,366 | 0 | 890,366 | SCHEDULE 13G, 2026-06-15 |
| Israel A. Englander | 0 | 890,366 | 0 | 890,366 | SCHEDULE 13G, 2026-06-15 |
| AQR Capital Management, LLC | 0 | 866,867 | 0 | 882,595 | SCHEDULE 13G, 2026-08-13 |
| AQR Capital Management Holdings, LLC | 0 | 866,867 | 0 | 882,595 | SCHEDULE 13G, 2026-08-13 |
| Sirenia Capital Management LP | 0 | 814,801 | 0 | 814,801 | SCHEDULE 13G/A, 2026-08-14 |
| Alex Silverstein | 0 | 814,801 | 0 | 814,801 | SCHEDULE 13G/A, 2026-08-14 |
The latest filing identifies Tonix Pharmaceuticals Holding Corp. by CUSIP 890260839 and gives its principal executive office as 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ 07922 (SCHEDULE 13G/A, 2026-08-14).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 5.7% | SCHEDULE 13G |
| 2025-10-17 | BlackRock, Inc. | 7.8% | SCHEDULE 13G/A |
| 2025-10-31 | The Vanguard Group | 6.35% | SCHEDULE 13G |
| 2025-12-31 | Point72 Asset Management, L.P. | 9.2% | SCHEDULE 13G |
| 2026-01-21 | BlackRock, Inc. | 6.7% | SCHEDULE 13G/A |
| 2026-01-30 | The Vanguard Group | 5.02% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-15 | Sirenia Capital Management LP | 8.8% | SCHEDULE 13G |
| 2026-05-15 | Point72 Asset Management, L.P. | 6.9% | SCHEDULE 13G/A |
| 2026-06-15 | Millennium Management LLC | 5.6% | SCHEDULE 13G |
| 2026-08-13 | AQR Capital Management, LLC | 5.54% | SCHEDULE 13G |
| 2026-08-14 | Sirenia Capital Management LP | 4.9% | SCHEDULE 13G/A |
Questions about who owns Tonix Pharmaceuticals Holding Corp.
Who owns Tonix Pharmaceuticals Holding Corp.?
On this page, 4 holders' latest ownership filings report 5% or more of Tonix Pharmaceuticals Holding Corp.: Point72 Asset Management, L.P. (6.9%, Schedule 13G/A, filed 2026-05-15), BlackRock, Inc. (6.7%, Schedule 13G/A, filed 2026-01-21), Millennium Management LLC (5.6%, Schedule 13G, filed 2026-06-15) and AQR Capital Management, LLC (5.54%, Schedule 13G, filed 2026-08-13).
Who are the largest shareholders of Tonix Pharmaceuticals Holding Corp.?
By the share each holder's latest filing reports, the largest holders of Tonix Pharmaceuticals Holding Corp. on this page are Point72 Asset Management, L.P. (6.9%), BlackRock, Inc. (6.7%) and Millennium Management LLC (5.6%).
When did Point72 Asset Management, L.P. buy into Tonix Pharmaceuticals Holding Corp.?
The filings give report dates, not purchase dates. The earliest filing from Point72 Asset Management, L.P. on this page is the Schedule 13G, filed 2025-12-31, reporting 9.2%; its latest, Schedule 13G/A filed 2026-05-15, reports 6.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Tonix Pharmaceuticals Holding Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.